Diabetes research collaboration can pave the way for innovation
By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 November 2021 Charlotte Ling leads a research group in epigenetics and diabetes at Lund University. Emma Nilsson and Jones Ofori are two of the team members. Photo: Kennet Ruona Metformin is often described as the first-line medication for the treatment of type 2 diabetes. However, not all patients respond to the drug.
https://www.ludc.lu.se/article/diabetes-research-collaboration-can-pave-way-innovation - 2025-01-13